Clopidogrel reduced a composite of death from any cause, myocardial infarction (MI), or stroke events by an absolute 2.2 ...

Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

Researchers have found in a new research that switching from ticagrelor to clopidogrel in acute myocardial infarction (AMI) ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

The following is a summary of "Variations in Antithrombotic Prescriptions and Evaluation of Extended Clopidogrel Therapy ...

25). After a median follow-up of over two years, patients taking clopidogrel were 29% less likely than those taking aspirin to experience the trial's primary composite endpoint of all-cause death ...

Opens in a new tab or window CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as ...

We sought to compare the effectiveness and safety of acetylsalicylic acid (ASA) and ticagrelor or clopidogrel in patients with acute coronary syndrome from a single tertiary academic centre in ...